Rodgers, Griffin
- National Heart, Lung, and Blood Institute (no department on record)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #3,985
- Sustained Excellence
- Long-Funded
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
NIH Funding · FY2023
Linked Award Amount
$1.9M
Full award amounts, FY2023
Award Records
3
Records listing this PI
Award-Linked Rank
#3,985
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Rodgers, Griffin as a PI. Multi-PI records show the full award amount for context.
- 1ZIAHL006006-09ZIAContact PIRecombinant erythroid Kruppel-like factor fused to GATA1 upregulates globin expr$659.9Kaward amount
- 1ZIAHL006003-16ZIAContact PIOlfactomedin 4 Suppresses Prostate Cancer Cell Growth and Metastasis via Negativ$640.5Kaward amount
- 1ZIAHL006004-16ZIAContact PIOlfactomedin 4- a key regulator of human neutrophil function, role in small intestinal adenocarcinoma.$640.5Kaward amount
Award organization
Organizations that administered FY2023 awards listing Rodgers, Griffin as a PI.
FY2023 award administered by National Heart, Lung, and Blood Institute ().
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2008First NIH AwardNational Heart, Lung, and Blood Institute
- 2008$500K Cumulative Funding
- 2008$1M Cumulative Funding
- 2008Entered Top 50% NationallyRanked #5556
- 2009$2M Cumulative Funding
- 2010$5M Cumulative Funding
- 2010Entered Top 25% NationallyRanked #2184
- 2011Entered Top 10% NationallyRanked #1279
- 2012$10M Cumulative Funding
- 2022$25M Cumulative Funding